Valerie Mbella

Senior Director & Leader - Global Regulatory Affairs Diagnostics Johnson & Johnson

Seminars

Wednesday 20th May 2026
Panel Discussion: Discussing Decision Making by Regulatory Bodies & Aligning Development Strategy to Meet Regulatory Standards within Japan & Internationally
11:30 am
  • Examining how PMDA decision-making processes compare with FDA and EMA expectations, and what this means for global CDx and therapeutic development planning
  • Identifying practical strategies to align clinical evidence generation, submission timing, and stakeholder engagement to meet both Japanese and international regulatory standards
Valerie Mbella - Senior Director, Global Regulatory Affairs, Diagnostics Leader, Johnson & Johnson Innovative Medicine